Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 19, 2005

View Archived Issues

GTx receives response on SPA for Acapodene for prevention of prostate cancer

Novavax and Wave Biotech to collaborate on production processes

Quarterly activities at Medivir

In vivo efficacy of novel p38alpha MAP kinase inhibitors from BMS

A-761: Novel MCHR1 antagonist with in vivo efficacy and cardiovascular safety

Novel selective adenosine A2A receptor antagonist with anticataleptic activity in vivo

Adjuvant trastuzumab increases survival in early-stage breast cancer

Trans NV-04 reported to reduce cardiovascular risk in overweight subjects

Promising effects of MC-4232 in patients with diabetic hypertension

Phase II data on the benefits of once-daily SPD-476 in ulcerative colitis

Rosiglitazone improves treatment satisfaction in elderly patients with type 2 diabetes

LEO Pharma and Warner Chilcott expand U.S. dermatology cooperation

Myozyme studied for late-onset Pompe disease

Cyclacel and Genzyme sign agreement for CDK inhibitors for renal disease

Huntsman Cancer Institute funded to study Curacyte's PHP

Keppra meets primary endpoint in phase III monotherapy epilepsy study

Dendreon plans Provenge BLA filing

Aplaviroc studies in treatment-naive HIV patients halted over liver toxicity

Macugen recommended for approval in Europe

New therapeutics for cancer disclosed in recent patents

Adartrel receives positive opinion in Europe for restless legs syndrome

Shionogi launches antibiotic Finibax in Japan

Novel immunomodulating agents revealed in patents

Once-monthly Bonviva approved in E.U. for postmenopausal osteoporosis

Clinical evidence supports the use of duloxetine for DPNP

Pranlukast induces neuroprotective effects in a model of cerebral ischemia

New data on the effects of DiaPep277 in patients with type 1 diabetes

Update on the effects of rubitecan in advanced NSCLC

Final phase I data on OGX-011 in prostate cancer

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment
BioWorld Science
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...